IRIS
TOFFOLETTI, Eleonora
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.470
EU - Europa 788
AS - Asia 453
SA - Sud America 52
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 3.778
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.454
SG - Singapore 229
UA - Ucraina 194
CN - Cina 137
IT - Italia 113
DE - Germania 112
RU - Federazione Russa 77
FI - Finlandia 71
SE - Svezia 71
BR - Brasile 41
TR - Turchia 36
FR - Francia 35
IE - Irlanda 35
GB - Regno Unito 24
BE - Belgio 14
VN - Vietnam 14
KR - Corea 13
CA - Canada 11
IN - India 11
CO - Colombia 10
CZ - Repubblica Ceca 9
AT - Austria 6
EG - Egitto 6
RO - Romania 5
BD - Bangladesh 3
BG - Bulgaria 3
CH - Svizzera 3
ES - Italia 3
EU - Europa 3
NL - Olanda 3
AU - Australia 2
HK - Hong Kong 2
HN - Honduras 2
HU - Ungheria 2
JP - Giappone 2
PL - Polonia 2
RS - Serbia 2
TG - Togo 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BH - Bahrain 1
GE - Georgia 1
GL - Groenlandia 1
HR - Croazia 1
IQ - Iraq 1
JM - Giamaica 1
KG - Kirghizistan 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MA - Marocco 1
MX - Messico 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 3.778
Salva come PNG Salva come JPEG
Città #
Woodbridge 298
Ann Arbor 284
Chandler 251
Fairfield 238
Houston 172
Singapore 153
Ashburn 139
Jacksonville 130
Seattle 108
Wilmington 89
Dearborn 86
Beijing 76
Cambridge 66
Udine 53
Boardman 47
Princeton 36
Dublin 35
Izmir 35
Trieste 22
San Diego 17
Brussels 14
Dong Ket 14
Los Angeles 13
Des Moines 11
New York 11
Seoul 11
Bogotá 10
Dallas 10
Munich 10
Ogden 10
Turku 10
Redmond 8
Phoenix 7
Düsseldorf 6
Frankfurt am Main 6
Helsinki 6
Kunming 6
Nuremberg 6
Cairo 5
Grafing 5
Hefei 5
Milan 5
Norwalk 5
Ottawa 5
Prague 5
Vienna 5
Lauterbourg 4
Nanjing 4
Toronto 4
Atlanta 3
Guangzhou 3
Maceió 3
Madrid 3
Ningbo 3
Shanghai 3
Sofia 3
São Paulo 3
Washington 3
Zurich 3
Belgrade 2
Boston 2
Brno 2
Chengdu 2
Chicago 2
Contagem 2
Goiânia 2
Hebei 2
Hong Kong 2
Horia 2
Hyderabad 2
Jiaxing 2
Licata 2
Lomé 2
Olomouc 2
Pune 2
San Francisco 2
Simi Valley 2
Tokyo 2
Valdobbiadene 2
Warsaw 2
Wuhan 2
Adelaide 1
Ambrolauri 1
Amsterdam 1
Augusta 1
Baotou 1
Barueri 1
Basra 1
Bauru 1
Bexley 1
Birmingham 1
Bishkek 1
Brooklyn 1
Bucharest 1
Budapest 1
Calgary 1
Capelinha 1
Capivari 1
Catanzaro 1
Cavarzere 1
Totale 2.649
Salva come PNG Salva come JPEG
Nome #
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 192
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors 152
Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia. 149
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 147
Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia 141
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years 140
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. 139
B-cell immune reconstitution after allogenic stem cell transplantation and its role in the development of chronic graft-versus-host disease 135
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 131
Clonality and phenotype in spleens from patients with primary immune thrombocytopenia. 128
Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donor 128
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. 126
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories 122
Longitudinal follow-up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogeneic bone marrow transplant 119
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia 115
High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission 114
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy. 112
null 111
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 109
The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations. 106
KERATOCONJUNCTIVITIS TREATMENT WITH AUTOLOGOUS SERUM EYE IN PATIENTS WITH SEVERE CHRONIC GVHD 102
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 102
T-cell chimerism and clinical outcome after reduced-intensity conditioning allogeneic stem cell transplantation 101
KIR POLYMORPHISM IN REDUCED INTENSITY HLA-ID SIBLING STEM CELL TRANSPLANTATION: IMPACT ON CLINICAL OUTCOME 98
No evidence for B-cell clonality by spectratyping analysis in patients with idiopathic thrombocytopenic purpura undergoing rituximab therapy” 85
Fludarabine-based induction therapy does not overcome the negative effect of bcrp (ABCG2) overexpression on remission duration in adult de novo acute myeloid leukemia patients 81
OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANT FOR REFRACTORY AND RELAPSED ACUTE MYELOID LEUKEMIA 71
MONITORING OF MINIMAL RESIDUAL DISEASE BY QUANTITATIVE WT1 GENE EXPRESSION AFTER REDUCED INTENSITY CONDITIONING ALLOGENEIC SCT IN ACUTE MYELOID LEUKEMIA 68
Longitudinal follow up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogenic bone marrow transplant 68
QUANTITATIVE ANALYSIS OF MN1 GENE EXPRESSION FOR EVALUATION OF MINIMAL RESIDUAL DISEASE IN CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA PATIENTS 68
Clinical presentation, outcome and risk factors of late-onset non-infectious pulmonary complication after allogeneic transplantation 65
CONCOMITANT OVEREXPRESSION OF BCRP AND FLT3-ITD MUTATION ARE ASSOCIATED WITH POOR PROGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS 64
Monitoring of minimal residual disease by quantitative WT1 gene expression following reduce intensity conditioning allogenic stem cell transplantation in acute myeloid leukaemia 55
MULTICENTER PROSPECTIVE CLINICAL TRIAL WITH LOW DOSE GEMTUZUMAB-OZOGAMICIN PLUS FLUDARABINE, CYTARABINE, IDARUBICIN (GO-FLAI) AS INDUCTION THERAPY OF CD33-POSITIVE ACUTE MYELOID LEUKEMIA (AML) PATIENTS YOUNGER THAN 65 YEARS 50
JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response 48
WT1 – Gene expression driven pre-emptive treatment with decitabine for molecular relapse of acute myeloid leukemia after allogeneic stem cell transplant 42
BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment-free remission: A study from the “GRUPPO TRIVENETO LMC” 34
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias 29
Expression and modulation of S100A4 protein by human mast cells 19
Optimal timing of molecular monitoring after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia 17
Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study 16
New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers 10
Totale 3.909
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.048
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202072 0 0 0 0 0 0 0 0 0 0 19 53
2020/2021479 10 44 11 51 15 49 27 47 85 21 87 32
2021/2022368 18 35 16 21 22 9 22 10 10 54 96 55
2022/2023531 52 48 5 80 48 116 3 61 71 11 24 12
2023/2024143 19 16 5 4 20 18 2 8 14 8 7 22
2024/2025583 23 55 17 22 63 25 65 49 93 45 126 0
Totale 3.909